Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
dfwl28's Profile
Displaying 551-600 of 801 result(s).
CYDY CytoDyn Inc
02/08/2021 2:56:05 PM
Pass your ideas on to the company.
CYDY CytoDyn Inc
02/05/2021 10:56:13 AM
Memo to the FDA The Lancet:: “In
CYDY CytoDyn Inc
02/04/2021 2:05:38 PM
There is an ongoing trial being con
CYDY CytoDyn Inc
02/04/2021 11:46:36 AM
. I imagine if it works they'd be p (2)
CYDY CytoDyn Inc
02/02/2021 3:40:23 PM
there should be a relatively short (4)
CYDY CytoDyn Inc
01/31/2021 9:46:46 AM
“This effort will be unlikely to (2)
CYDY CytoDyn Inc
01/30/2021 4:50:11 PM
If the FDA wants our data as soon
CYDY CytoDyn Inc
01/30/2021 11:19:14 AM
True enough. The Times has strong b
CYDY CytoDyn Inc
01/24/2021 4:32:27 PM
Attention Nader bashers; Nader: Dr. (5)
CYDY CytoDyn Inc
01/23/2021 2:13:56 PM
Quote: Several hopefuls before admi (2)
CYDY CytoDyn Inc
01/23/2021 2:10:16 PM
XW013K6 Introduction of Leronlimab
CYDY CytoDyn Inc
01/23/2021 2:05:38 PM
Additionally, from what I've been t
CYDY CytoDyn Inc
01/23/2021 12:01:33 PM
https://breast-cancer-research.bio (3)
CYDY CytoDyn Inc
01/21/2021 10:27:59 PM
bucsweeny:I’m not here to cast do (2)
CYDY CytoDyn Inc
01/21/2021 11:51:40 AM
"BP believe RO is a better test tha
CYDY CytoDyn Inc
01/21/2021 10:43:36 AM
I'm thinking, (?wrongly?), that RO (4)
CYDY CytoDyn Inc
01/20/2021 2:27:00 PM
"And we are only seeing a few milli (1)
CYDY CytoDyn Inc
01/19/2021 1:36:42 PM
Abstract excerpt: "New evidence on (4)
CYDY CytoDyn Inc
01/13/2021 5:59:07 PM
havasu: Help me understand. I'm a l (2)
CYDY CytoDyn Inc
01/13/2021 7:47:39 AM
By definition doesn't having the de (3)
CYDY CytoDyn Inc
01/11/2021 7:54:10 PM
CCR5 antagonism is a totally new,
CYDY CytoDyn Inc
01/07/2021 4:55:15 PM
". A 33% mortality reduction should (3)
CYDY CytoDyn Inc
01/06/2021 12:09:07 PM
Excerpt: Our data provide new insig (2)
CYDY CytoDyn Inc
01/04/2021 1:26:19 PM
ohms message on stocktwits 09:15 AM (1)
CYDY CytoDyn Inc
01/01/2021 3:58:06 PM
"Gates has billions invested in dru (4)
CYDY CytoDyn Inc
01/01/2021 3:18:10 PM
"Long hauler disease anything but a (1)
CYDY CytoDyn Inc
01/01/2021 1:20:12 PM
"Government would be wise " to sto (1)
CYDY CytoDyn Inc
12/29/2020 11:02:09 PM
Not quite, but one trail I may even
CYDY CytoDyn Inc
12/28/2020 2:41:30 PM
NASH trial is a non-factor until la (1)
CYDY CytoDyn Inc
12/28/2020 2:32:03 PM
Thank you OHM.. Got it.
CYDY CytoDyn Inc
12/28/2020 11:53:01 AM
first patient first visit metric wa (1)
CYDY CytoDyn Inc
12/28/2020 7:07:34 AM
CytoDyn ....announced today the fir (2)
CYDY CytoDyn Inc
12/27/2020 7:38:10 AM
I think he’s (MD) just trying to (1)
CYDY CytoDyn Inc
12/26/2020 12:41:06 PM
This looks like we need EUA in the (4)
CYDY CytoDyn Inc
12/25/2020 12:47:23 PM
Open Label Excerpt: We still have t (3)
CYDY CytoDyn Inc
12/25/2020 12:37:25 PM
Lee ron, thanks again, and that LED
CYDY CytoDyn Inc
12/23/2020 6:18:09 PM
Rep.-elect Luke Letlow (R-La.) has
CYDY CytoDyn Inc
12/23/2020 11:32:56 AM
He is a CFO, so Financial is his mi (1)
CYDY CytoDyn Inc
12/23/2020 8:25:19 AM
Merck sound like it has a real comp (1)
CYDY CytoDyn Inc
12/21/2020 1:32:35 PM
Can you please expand on this issue
CYDY CytoDyn Inc
12/21/2020 1:32:10 PM
Can you expand on this issue. hyper
CYDY CytoDyn Inc
12/20/2020 9:32:13 PM
"Come on DSMC and FDA, prove me wro (1)
CYDY CytoDyn Inc
12/20/2020 7:24:29 PM
Obviously the author does not know
CYDY CytoDyn Inc
12/18/2020 9:50:01 PM
You’re the exact kind of investor (3)
CYDY CytoDyn Inc
12/17/2020 5:10:17 PM
NIH - None are so blind as those wh (1)
CYDY CytoDyn Inc
12/17/2020 6:21:55 AM
Insider Financial excerpt: "What h (1)
CYDY CytoDyn Inc
12/15/2020 4:20:41 PM
CYDY: VANCOUVER, Washington, Dec. 1 (1)
CYDY CytoDyn Inc
12/11/2020 10:14:40 AM
Personally, I am not tired of these (5)
CYDY CytoDyn Inc
12/10/2020 5:25:00 PM
Forget Philippines. That is a Hail (2)
CYDY CytoDyn Inc
12/10/2020 5:12:22 PM
We could know? a full on - complete
Go to page:
  • << First
  • < Previous
  • 11
  • 12
  • Next >

Recent Articles

  • Compass Diversified Faces Investor Concerns over Recent Irregularities
  • Endeavour Silver Reports Strong Q2 Production Results
  • Ryan Barone of RentRedi Selected as Future Leader in Real Estate
  • Revolutionizing Air Travel Communication with AI Integration
  • Arcadia Cognerati Welcomes Daniel Chavez to Leadership Role
  • Arcadia Cognerati Welcomes Daniel Chavez as Training VP
  • Westbridge Renewable Energy Unveils Ambitious Data Centre Project
  • WCAS Transforms AIA Contract Documents Through Strategic Investment
  • Brookdale Senior Living Sees Positive Occupancy Trends
  • i-80 Gold Corp's Advances in Development Strategy Unveiled
  • Endeavour Silver Achieves Impressive Production Growth in Q2 2025
  • Caristo Diagnostics Showcases Innovative Cardiac Technology at SCCT
  • Brookdale Urges Shareholders to Support Qualified Directors
  • Canada Carbon Secures Permits for Third Asbury Drilling
  • Microbix Biosystems Partners with Bulgaria’s NCIPD for Growth
  • ProKidney's Rilparencel Trial Shows Promise for CKD Patients
  • Agios Pharmaceuticals Welcomes Dr. Jay Backstrom to Board of Directors
  • Adagene Partners with ConjugateBio to Advance Antibody Treatments
  • Exploring the Potential of a Dual Role for Bessent
  • Larimar Therapeutics Elevates Research on Nomlabofusp's Promise
  • Discovering the Future of Agriculture with AI and ADM
  • Upstream Bio Begins Clinical Trial to Treat COPD with Verekitug
  • Energous Achieves Record Revenue and Milestones in Q2 2025
  • Eupraxia Advances EP-104GI into Phase 2b Study for EoE Treatment
  • Liquidity Services Prepares for Exciting Earnings Call Ahead
  • Plymouth Industrial REIT Reports Robust Growth and Leasing Activity
  • CervoMed to Showcase Groundbreaking Research at AAIC 2025
  • Jade Biosciences Engages Investors at Key Upcoming Conferences
  • Microbix Partners with NCIPD for Pathogen Seedstock Supply
  • Nobel Resources Expands Exploration Insights at Cuprita Project
  • Diagonal Therapeutics Welcomes Dr. John Lee as CMO
  • Churchill Reports Positive High-Grade Zinc Assay Results
  • Plymouth Industrial REIT's Q2 2025 Performance Insights
  • PyroGenesis Achieves Enhanced Quality in Fumed Silica Production
  • Agios Welcomes Dr. Jay Backstrom as New Board Member
  • Vaxart, Inc. Begins Trading on OTCQX Best Market
  • Jade Biosciences Set for Engaging Investor Conferences Ahead
  • Calian Expands Commitment to Canadian Armed Forces Health Care
  • Honeywell's Strategic Reassessment to Enhance Automation Solutions
  • Calian Strengthens Commitment to Canadian Military with New Deal
  • H2O America’s Growth Surge: Quadvest Acquisition Expands Reach
  • H2O America Strengthens Position with Quadvest Acquisition
  • NexGold Gains Key Approval for Goldboro Project Expansion
  • Cryptocurrency Market Insights Amidst Varied Trends
  • Introducing Undercover: A $200 Million Global Cargo Solution
  • UCB Expands BIMZELX Campaign to Support HS Community Growth
  • BlackRock's Bitcoin ETF Reaches New Heights with 700,000 BTC
  • N2K and TAC Collaborate to Elevate Cybersecurity Training
  • EDF Strengthens Governance to Boost Nuclear and Hydropower Efforts
  • BlackRock's Upcoming Earnings: Analysts Adjust Expectations
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site